National Cancer Drugs Fund Application Form – Sorafenib For Papillary or Follicular Thyroid Cancer Author(s) David Thomson Owner Chemotherapy Clinical Reference Group Version Control Version Control Date Revision summary Ver2.0 14 Jul 2014 Introduction of version control and addition of section re-SACT and monitoring Change to current version Criteria Changes N/A Introduction of version control and addition of section re-SACT and monitoring
National Cancer Drugs Fund Application Form – Sorafenib For Papillary or Follicular Thyroid Cancer Author(s) David Thomson Owner Chemotherapy Clinical Reference Group Version Control Version Control Date Revision summary Ver2.0 14 Jul 2014 Introduction of version control and addition of section re-SACT and monitoring Change to current version Criteria Changes N/A Introduction of version control and addition of section re-SACT and monitoring
SOR2_v2.0_Sorafenib_Thyroid.docx